Profound Medical Revenue vs. Price To Book

PROF Stock  USD 8.44  0.04  0.47%   
Taking into consideration Profound Medical's profitability measurements, Profound Medical Corp may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in February. Profitability indicators assess Profound Medical's ability to earn profits and add value for shareholders.
 
Total Revenue  
First Reported
2017-03-31
Previous Quarter
2.2 M
Current Value
5.2 M
Quarterly Volatility
1.3 M
 
Covid
At this time, Profound Medical's EV To Sales is most likely to increase significantly in the upcoming years. The Profound Medical's current Sales General And Administrative To Revenue is estimated to increase to 1.63, while Operating Cash Flow Sales Ratio is projected to decrease to (2.08). At this time, Profound Medical's Interest Income is most likely to increase significantly in the upcoming years. The Profound Medical's current Net Interest Income is estimated to increase to about 1.7 M, while Income Before Tax is projected to decrease to (25 M). The Profound Medical's current Gross Profit is estimated to increase to about 8.1 M, while Pretax Profit Margin is projected to decrease to (2.46).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.390.59
Way Down
Slightly volatile
For Profound Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Profound Medical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Profound Medical Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Profound Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Profound Medical Corp over time as well as its relative position and ranking within its peers.

Profound Medical's Revenue Breakdown by Earning Segment

Check out Your Equity Center.
The next projected EPS of Profound Medical is estimated to be -0.2567 with future projections ranging from a low of -0.3 to a high of -0.23. Profound Medical's most recent 12-month trailing earnings per share (EPS TTM) is at -1.32. Please be aware that the consensus of earnings estimates for Profound Medical Corp is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Yuan Drop
 
Covid
Profound Medical is projected to generate -0.2567 in earnings per share on the 31st of March 2026. Profound Medical earnings estimates show analyst consensus about projected Profound Medical Corp EPS (Earning Per Share). It derives the highest and the lowest estimates based on Profound Medical's historical volatility. Many public companies, such as Profound Medical, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

Profound Medical Revenue Breakdown by Earning Segment

By analyzing Profound Medical's earnings estimates, investors can diagnose different trends across Profound Medical's analyst sentiment over time as well as compare current estimates against different timeframes.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Profound Medical. If investors know Profound will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Profound Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.32)
Revenue Per Share
0.492
Quarterly Revenue Growth
0.868
Return On Assets
(0.62)
Return On Equity
(1.24)
The market value of Profound Medical Corp is measured differently than its book value, which is the value of Profound that is recorded on the company's balance sheet. Investors also form their own opinion of Profound Medical's value that differs from its market value or its book value, called intrinsic value, which is Profound Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Profound Medical's market value can be influenced by many factors that don't directly affect Profound Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Profound Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Profound Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Profound Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Profound Medical Corp Price To Book vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Profound Medical's current stock value. Our valuation model uses many indicators to compare Profound Medical value to that of its competitors to determine the firm's financial worth.
Profound Medical Corp is rated top company in revenue category among its peers. It also is considered to be number one stock in price to book category among its peers . The ratio of Revenue to Price To Book for Profound Medical Corp is about  1,066,897 . At this time, Profound Medical's Total Revenue is most likely to increase significantly in the upcoming years. Comparative valuation analysis is a catch-all technique that is used if you cannot value Profound Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Profound Revenue vs. Competition

Profound Medical Corp is rated top company in revenue category among its peers. Market size based on revenue of Health Care industry is at this time estimated at about 36.67 Million. Profound Medical totals roughly 10.17 Million in revenue claiming about 28% of equities under Health Care industry.

Profound Price To Book vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Profound Medical

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
10.17 M
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

Profound Medical

P/B

 = 

MV Per Share

BV Per Share

 = 
9.53 X
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.

Profound Price To Book Comparison

Profound Medical is currently under evaluation in price to book category among its peers.

Profound Medical Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Profound Medical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Profound Medical will eventually generate negative long term returns. The profitability progress is the general direction of Profound Medical's change in net profit over the period of time. It can combine multiple indicators of Profound Medical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income3.2 M3.4 M
Operating Income-28.3 M-29.7 M
Income Before Tax-23.8 M-25 M
Total Other Income Expense Net5.7 MM
Net Loss-25 M-26.3 M
Income Tax Expense-2.2 K-2.1 K
Interest Income1.9 MM
Net Loss-25 M-26.3 M
Net Loss-25.8 M-27.1 M
Net Interest Income1.7 M1.7 M
Change To Netincome7.9 M4.6 M
Net Loss(1.01)(1.06)
Income Quality 0.76  0.62 
Net Income Per E B T 0.90  0.80 

Profound Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Profound Medical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Profound Medical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Profound Medical's important profitability drivers and their relationship over time.

Profound Medical Earnings Estimation Breakdown

The calculation of Profound Medical's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Profound Medical is estimated to be -0.2567 with the future projection ranging from a low of -0.3 to a high of -0.23. Please be aware that this consensus of annual earnings estimates for Profound Medical Corp is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
0.0
-0.3
Lowest
Expected EPS
-0.2567
-0.23
Highest

Profound Medical Earnings Projection Consensus

Suppose the current estimates of Profound Medical's value are higher than the current market price of the Profound Medical stock. In this case, investors may conclude that Profound Medical is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Profound Medical's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of March 2026Current EPS (TTM)
571.43%
0.0
-0.2567
-1.32

Profound Medical Earnings History

Earnings estimate consensus by Profound Medical Corp analysts from Wall Street is used by the market to judge Profound Medical's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Profound Medical's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.

Profound Medical Quarterly Gross Profit

3.89 Million

The Profound Medical's current Price Earnings To Growth Ratio is estimated to increase to 0.72, while Retained Earnings are forecasted to increase to (209.6 M). The Profound Medical's current Common Stock Shares Outstanding is estimated to increase to about 29.9 M, while Net Loss is projected to decrease to (27.1 M).
Hype
Prediction
LowEstimatedHigh
4.808.5312.26
Details
Intrinsic
Valuation
LowRealHigh
6.009.7313.46
Details
Naive
Forecast
LowNextHigh
4.878.6012.33
Details
5 Analysts
Consensus
LowTargetHigh
11.2412.3513.71
Details
Note that many institutional investors and large investment bankers can move markets due to the volume of Profound assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Profound Medical. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Profound Medical's stock price in the short term.

Profound Medical Earnings per Share Projection vs Actual

Actual Earning per Share of Profound Medical refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Profound Medical Corp predict the company's earnings will be in the future. The higher the earnings per share of Profound Medical, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Profound Medical Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Profound Medical, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Profound Medical should always be considered in relation to other companies to make a more educated investment decision.

Profound Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Profound Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
null
nullnullnullnull
2025-11-13
2025-09-30-0.380.260.64168 
2025-08-14
2025-06-30-0.27-0.52-0.2592 
2025-05-07
2025-03-31-0.2825-0.36-0.077527 
2025-03-05
2024-12-31-0.3225-0.20.122537 
2024-11-07
2024-09-30-0.3-0.38-0.0826 
2024-08-08
2024-06-30-0.29-0.280.01
2024-05-09
2024-03-31-0.3-0.260.0413 
2024-03-07
2023-12-31-0.32-0.42-0.131 
2023-11-02
2023-09-30-0.33-0.260.0721 
2023-08-09
2023-06-30-0.34-0.35-0.01
2023-05-10
2023-03-31-0.34-0.320.02
2023-03-07
2022-12-31-0.36-0.46-0.127 
2022-11-03
2022-09-30-0.38-0.240.1436 
2022-08-04
2022-06-30-0.4-0.280.1230 
2022-05-09
2022-03-31-0.43-0.40.03
2022-03-03
2021-12-31-0.37-0.49-0.1232 
2021-11-04
2021-09-30-0.28-0.29-0.01
2021-08-04
2021-06-30-0.28-0.35-0.0725 
2021-05-12
2021-03-31-0.27-0.37-0.137 
2021-03-02
2020-12-31-0.43-0.49-0.0613 
2020-11-05
2020-09-30-0.35-0.43-0.0822 
2020-08-06
2020-06-30-0.31-0.46-0.1548 
2020-05-07
2020-03-31-0.33-0.250.0824 
2020-03-03
2019-12-31-0.4923-0.3210.171334 
2019-11-07
2019-09-30-0.38-0.43-0.0513 
2019-08-14
2019-06-30-0.33-0.38-0.0515 
2019-05-06
2019-03-31-0.33-0.220.1133 
2019-03-07
2018-12-31-0.45-0.5-0.0511 
2018-11-08
2018-09-30-0.44-0.5-0.0613 
2018-08-14
2018-06-30-0.38-0.5-0.1231 
2018-05-10
2018-03-31-0.4-0.6-0.250 
2018-03-26
2017-12-31-0.5-0.6-0.120 
2017-11-07
2017-09-30-0.67-0.9-0.2334 
2017-08-23
2017-06-30-0.07-0.08-0.0114 
2017-05-09
2017-03-31-0.07-0.070.0
2017-03-06
2016-12-31-0.07-0.070.0
2016-11-16
2016-09-30-0.08-0.1-0.0225 
2016-08-18
2016-06-30-0.09-0.090.0
2016-05-06
2016-03-31-0.07-0.1-0.0342 

Use Profound Medical in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Profound Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Profound Medical will appreciate offsetting losses from the drop in the long position's value.

Profound Medical Pair Trading

Profound Medical Corp Pair Trading Analysis

The ability to find closely correlated positions to Profound Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Profound Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Profound Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Profound Medical Corp to buy it.
The correlation of Profound Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Profound Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Profound Medical Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Profound Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Profound Medical position

In addition to having Profound Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Convertibles Funds Thematic Idea Now

Convertibles Funds
Convertibles Funds Theme
Funds or Etfs that invest in debt that is expected to be converted into a predetermined amount of the company equity at some future date. The Convertibles Funds theme has 11 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Convertibles Funds Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Profound Medical Corp is a strong investment it is important to analyze Profound Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Profound Medical's future performance. For an informed investment choice regarding Profound Stock, refer to the following important reports:
Check out Your Equity Center.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
To fully project Profound Medical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Profound Medical Corp at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Profound Medical's income statement, its balance sheet, and the statement of cash flows.
Potential Profound Medical investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Profound Medical investors may work on each financial statement separately, they are all related. The changes in Profound Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Profound Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.